Clinical Trial Update: Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin combined with paclitaxel in advanced thymoma and thymic carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Thymoma, Thymic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2012-10-18